Post-inflammatory glomerular remodeling is influenced by transformed mesangial cells.
To identify the role of transformed mesangial cells (MC) during glomerular remodeling, anti-thymocyte-1 (Thy1) nephritis; modified Thy1 nephritis (injections of anti-Thy1 antibody four times, weekly); and Thy1 nephritis treated with signal transduction inhibitor 571 (Thy1 + STI); were analyzed. At week 1 the index of MC proliferation in modified Thy1 nephritis and in mesangiolysis in Thy1 + STI nephritis was highest among the three models. From week 4, the index of alpha-smooth muscle actin (alpha-SMA) was significantly higher in modified Thy1 nephritis than the other two models. Production of the mesangial matrix including type IV collagen was increased in modified Thy1 but inhibited in Thy1 + STI nephritis. In contrast to modified Thy1 nephritis, the capillary numbers in glomeruli recovered to normal at week 4 in Thy1, and at week 8 in Thy1 + STI nephritis. At week 12, both the adhesive and sclerotic index was significantly higher in modified Thy1 than in the other two models. Data suggest that a moderate amount of mesangial matrix results in a complete repair of capillary loops. Overproduction of the mesangial matrix retards capillary remodeling and finally induces glomerulosclerosis. Insufficient mesangial matrix delays the repair of capillary loops. In conclusion, transformed MC may influence glomerular remodeling by changing the amount of mesangial matrix.
Zhang
Lian-shan
LS
Department of Pathology, Shinshu University School of Medicine, Matsumoto, Japan. lianshan@sch.md.shinshu-u.ac.jp
Aoyagi
Daiju
D
Nakazawa
Koh
K
Otani
Masako
M
D000199:Actins / Q000032:analysis; D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000032:analysis / Q000276:immunology; D001549:Benzamides; D002196:Capillaries / Q000473:pathology; D024142:Collagen Type VI / Q000032:analysis; D005920:Glomerular Mesangium / Q000098:blood supply / Q000473:pathology* / Q000648:ultrastructure; D000068877:Imatinib Mesylate; D007150:Immunohistochemistry; D007249:Inflammation / Q000503:physiopathology; D007678:Kidney Glomerulus / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology*; D008264:Macrophages / Q000276:immunology; D008297:Male; D008854:Microscopy, Electron; D009000:Monocytes / Q000276:immunology; D009130:Muscle, Smooth / Q000737:chemistry; D009393:Nephritis / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology; D010879:Piperazines / Q000494:pharmacology; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D012598:Sclerosis; D018800:Thy-1 Antigens / Q000276:immunology
D000199:Actins; D000911:Antibodies, Monoclonal; D001549:Benzamides; D024142:Collagen Type VI; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D018800:Thy-1 Antigens; D000068877:Imatinib Mesylate